ACA
TARO

Avoro Capital Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Avoro Capital Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-53,800
Closed -$7.59M – 38
2015
Q1 		$7.59M Sell
53,800
-30,000
-36% -$4.62M 2.91% 11
2014
Q4 		$12.4M Buy
+83,800
New +$12.3M 8.41% 2

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Avoro Capital Advisors's TARO Position: Q2 2015 in Review

Avoro Capital Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2015, closing a stake of 53,800 shares — an estimated $7.59M sold.

Avoro Capital Advisors first reported a position in TARO in Q4 2014 and held it in 2 quarters. The position peaked at $12.4M in Q4 2014. 106 funds tracked by Wall St. Rank hold TARO as of Q2 2015.

  • Avoro Capital Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2015 after selling out during the quarter.
  • Avoro Capital Advisors sold 53,800 Taro Pharmaceutical Industries Ltd. shares in Q2 2015, an estimated $7.59M.
  • Avoro Capital Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 2 quarters.
  • Avoro Capital Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $12.4M in Q4 2014.
  • 106 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2015.

Based on Avoro Capital Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.